In order to elucidate the molecular mechanism underlying RBMS3's inhibitory effects on colon cancer progression, we performed RNA‐seq analyses on cells overexpressing RBMS3, cells with RBMS3 knocked down, and a control group. This evidence concerns the gene RBMS3 and colonic neoplasm.